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Abstract
Background: The emergence of multidrug resistant Staphylococcus aureus strains, including methicillin resistant
(MRSA), is a global concern. Treatment of bacterial infections in Uganda’s health care settings is largely empirical,
rarely accompanied by laboratory confirmation. Here we show the burden, characteristics of MRSA and epidemiology
of Panton-Valentine Leukocidin (PVL) positive strains in asymptomatic carriers in pastoral households of
south-west Uganda.
Methods: Nasal swabs from 253 participants were cultured following standard methodology. MRSA strains
were identified by detection of the mecA gene and SCCmec typing, and PVL genes detected by PCR. Pulsed
Field Gel Electrophoresis (PFGE) was done to evaluate possible transmission patterns. Spa typing of PVL
positive isolates was done to study the epidemiology of virulent strains in this setting.
Results: S. aureus was isolated in 29% (n = 73) of the participants, of which 48 were MRSA by mecA typing.
PVL-encoding genes were found in 49.3% (n = 36) of the 73 isolates, of which 25 were also mecA positive.
Among the PVL negative strains (n = 37), 62.2% (n = 23) carried the mecA gene. The most common SCCmec
type was V, detected in 39 (18 PVL positive and 21 PVL negative) isolates. PFGE clustered 21/36 (58.3%) PVL
positive isolates divided in four pulsotypes and 18/37 (48.6%) PVL negative isolates divided in eight pulsotypes. The
most prevalent Spa types were t318 (26.5%, n = 9) and t645 (20.6%, n = 7); while other common Spa types were t11656
(n = 3), t127 (n = 3) and t355 (n = 3).
Conclusion: The study shows a high prevalence of community acquired (CA)-MRSA, and PVL-positive isolates with two
predominant spa types in rural Uganda, further complicating infection control strategies in these underprivileged
communities.
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Background
About a third of healthy individuals in the community
are asymptomatically colonized with Staphylococcus
aures (S. aureus) in the nostrils [1], a very important
finding considering the fact that nasal carriage of S. aureus
has been associated with subsequent infection [2], and
carriers are an important source of spread of infection in
communities. A major concern is the world-wide emer-
gence of methicillin resistant S. aureus (MRSA) in the
community [3]. In contrast with health care associated
MRSA (HA-MRSA) infections, community associated
MRSA (CA-MRSA) infections can occur in healthy indi-
viduals [4], suggesting that these strains have greater viru-
lence. Skin and soft-tissue infections represent about 90%
of cases of CA-MRSA infection, mostly characterized by
abscesses or cellulitis with purulent drainage [3].
A predominant feature of CA-MRSA is the presence
of the Panton-Valentine Leukocidin (PVL) genes that en-
code a S. aureus exotoxin that induces lysis of mono-
cytes and neutrophil granulocytes [5]. Additionally, there
is evidence that PVL-positive S. aureus strains susceptible
to methicillin (MSSA) may be reservoirs for the develop-
ment of PVL-positive MRSA via the integration of the
staphylococcal cassette chromosome mec (SCCmec) ele-
ments including the mecA gene conferring methicillin re-
sistance [6]. Another key feature of CA-MRSA is that the
strains mainly harbor SCCmec types IV and V [7–9], and
a relationship between CA-MRSA, SCCmec type IV and V
and PVL has been confirmed in some studies [10, 11].
While efforts have been made to map out the geo-
graphical predominance and spread of different CA-
MRSA clones worldwide [3], little is known about its
magnitude and genetic composition in developing coun-
tries, especially in Africa. Molecular analytical tech-
niques such as pulsed field gel electrophoresis (PFGE),
multilocus sequence typing (MLST), spa and SCCmec
typing have been used to show both the spread and evolu-
tion of MRSA. PFGE is still considered the gold standard
for typing MRSA isolates, and is one of the most discrim-
inative typing methods [12]. While MLST is an excellent
tool for investigating clonal evolution of MRSA, it is ra-
ther expensive, labour intensive and time consuming. Se-
quences from the polymorphic region of the S. aureus
protein A (spa) gene have been used to develop a single-
locus sequence typing technique for MRSA [13] with a
discriminatory power between PFGE and MLST, and
ability to investigate both molecular evolution and out-
break situations [14], while remaining simple.
The resistance of S. aureus to methicillin is caused by
the mecA gene, located on a mobile genetic element, the
staphylococcal cassette chromosome mec (SCCmec) [7].
Currently, eleven main SCCmec types (I to XI) are
known [15], and Zhang et al. developed a multiplex PCR
for the characterization of SCCmec type I to V [16].
In African countries, CA-MRSA has been reported in
a few studies in Mali [17], Nigeria [18], Algeria [19],
Egypt [20] and Gabon [21]. In Uganda, a few studies
have been done at tertiary health care centers [22–25],
and these have focused on HA-MRSA. Community studies
have focused on S. aureus carriage in raw milk and its
products as well as in urban milk vendors [26, 27]. We set
out to establish the prevalence and molecular epidemiology
of PVL-positive CA-MRSA isolates from pastoral commu-
nities of rural south-western Uganda so as to inform public
health on how to develop effective strategies to prevent
spread MRSA in these and surrounding communities.
Methods
Study area
The study was carried out in rural pastoral households
of Kiruhura district, South Western Uganda. The area is
a rangeland, populated by agro-pastoralists and season-
ally itinerant semi-nomads whose livelihoods mainly de-
pend on consumption and trade of cattle and their
products; and small subsistent crop farming.
Study design and sampling
A cross-sectional study of S. aureus carriage in the area
was conducted as part of a zoonotic diseases study
among pastoral communities of Kiruhura district, South
Western Uganda, in 2013. A total of 196 homesteads
from two sub-counties (100 from Kanyaryeru and 96
from Sanga) were recruited and sampled. The sub-
counties were purposively selected by the zoonoses study
because they bordered Lake Mburo National Park, with
a porous human-animal interface. All participants did
not have a history of recent hospitalization, and the only
demographics characteristics recorded were sex and self-
reported age. In each household, only a nasal swab was
taken for any participant and these were inoculated into
Brain-Heart Infusion (BHI) broth in 15 ml propylene
tubes and stored on ice before same day transportation
to the Department of Microbiology at Mbarara University
of Science and Technology for culture.
Sample culture, isolation and identification
Initial bacterial culture and isolation was done according
to methods described by Cheesbrough [28], with minor
modifications. Briefly, 50 μl of culture broth was inocu-
lated on 5% sheep blood agar medium and incubated for
18–20 h at 37 °C. Preliminary identification of the bac-
teria was carried out based on colony characteristics
such as shape, size, color and hemolysis patterns. Iso-
lates suspected of being S. aureus were shipped in BHI
with 20% glycerol to the Emerging Bacterial Pathogens
Unit (EBPU) at San Raffaele Scientific Institute in Milan,
Italy, for identification and molecular characterization.
At the EBPU, all isolates were sub-cultured on mannitol
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salt agar (Oxoid Ltd, Hampshire, England), then on blood
agar (Becton Dickinson, Heidelberg, Germany), and sub-
jected to the tube coagulase test in rabbit plasma with
EDTA (Remel, KS, USA). MRSA strains were identified by
detection of the mecA gene and SCCmec typing.
DNA extraction, SCCmec typing and PVL genes detection
Bacterial DNA was prepared from isolated colonies sus-
pended in 500 μl Triton X-100 lysis buffer with 1% Triton
and 20 μl of 1 mg/ml lysostaphin, incubated at 37 °C for
1 h, followed by phenol-chloroform extraction. SCCmec
typing was done by multiplex PCR using primers and pro-
tocols for SCCmec types and subtypes I, II, III, IVa, IVb,
IVc, IVd, and V and the mecA gene according to Zhang
et al. [16]. The MRSA strain COL (SCCmec type I, mec
gene complex B and ccr gene complex 1) was used as
positive control. Additionally, amplification of the
Panton – Valentine Leucocidin (PVL) toxin genes, lukS-
PV and lukF-PV, was performed using the S. aureus
strain ATCC49775 as positive control, and primers and
protocols as described by Lina et al. [29].
Genotyping of isolates
All isolates were subjected to molecular epidemiological
analysis by PFGE after SmaI digestion using the CHEF
Genomic DNA Plug kit (Bio-Rad) according to a stan-
dardized protocol [30]. PFGE was run using a CHEF
DRIII system (Bio-Rad). The InfoQuest FP (v5.1) soft-
ware (Bio-Rad Laboratories) was used to analyze PFGE
profiles, according to interpretation criteria described by
Tenover et al. [12]. Clustering analysis was achieved
using Dice similarity coefficients and the unweighted
pair group method with averages (UPGMA) at 1.5%
optimization and 1.5% position tolerance. PVL-positive
strains were further subjected to spa-typing according to
Frenay et al. [13]; and spa types were assigned on the
Ridom SpaServer (http://spaserver.ridom.de) curated by
the SeqNet.org initiative [31].
Results
Socio-demographic characteristics and S. aureus carriage
The study sampled 196 households, and nasal swabs
were taken from 253 participants (172 males and 81
females) with average age of 14 years and a range of 6 to
48 years. Of the samples, 132 (52.2%) were Staphylococcus
spp, of which only 73 were S. aureus (carriage rate of 29%)
and further characterized. The 73 isolates were obtained
from 48 (65.7%) males and 25 (34.3%) females. The aver-
age age of the 73 participants whose isolates were charac-
terized was 13, with a range of 6 to 45 years.
Prevalence of PVL and mecA genes
PVL-encoding genes were found in 49.3% (n = 36) of
the 73 S. aureus isolates, while mecA was detected in
65.8% (n = 48) of the 73 isolates. The proportion of
PVL positive isolates carrying the mecA gene was 25/36
(69.4%) (Table 1), while 23/37 (62.2%) of the isolates
without the PVL gene possessed the mecA (Table 2).
Among the PVL positive isolates, 18 of the 25 mecA
Table 1 PFGE profiles, Spa types, mecA, and SCCmec types of
PVL positive isolates
Isolate ID Pulsotype Spa type mecA SCCmec
T095Na A1 NT + V
T101Na A1 NT + IVc
T047Na A1 t127 + IVc
T070Na A1 t127 + IVc
T056N A2 t318 - -
T099Nd A3 t2393 + IVc
T149Na A4 t645 + IVc
T101Ng A5 t318 + V
T005Na B1 t318 + V
T021Nb B1 t318 + V
T021Nc B1 t318 + V
T097Na B1 t318 + V
T125Na B1 t318 + V
T141Nc B1 t318 + V
T047Nd B1 t186 + V
T156N B1 t186 + V
T019N B2 t186 + V
T119Nb C1 t355 + V
T135Na C2 t729 - -
T132Nb C2 t11656 - -
T139N C2 t11656 + V
T145N C2 t11656 + V
T022N C2 t645 - -
T041Na C2 t645 - -
T099Nb C2 t645 + V
T063N C3 t355 + V
T053N D1 t1376 + IVc
T055N D1 t1376 + V
T039Na E1 t318 + IVc
T041Nb E2 t645 + V
T025N E3 t2393 + IVc
T030Nb F1 t064 + V
T158Nb G1 t127 - -
T087 H1 t064 + V
T155Nd H2 t509 - -
T097Nb I1 t002 - -
ID identification number of the isolate, + positive on PCR amplification, - negative
on PCR amplification, NT not typable
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positive isolates were SCCmec type V, while the other
seven were all SCCmec IVc. Among the PVL negative
isolates, 21 of the 23 mecA positive isolates were
SCCmec type V, while the other two were type IVa.
Molecular epidemiology of MRSA PVL positive and PVL
negative strains
PFGE profiles of PVL positive and negative isolates were
analyzed separately to understand any difference in
transmission within the two groups. Among the PVL
positive isolates, 21/36 (58.3%) strains were found in
four clusters (A1, B1, C2, D1, Table 1); while in PVL
negative isolates, 18/37 (48.6%) were found in eight clus-
ters (E1, L1, L3, F1, N1, H1, G1, Q1, Table 2). Some
family members carried identical strains. In order to re-
late the genotypes of the isolates in this study to global
epidemiology of S. aureus, we performed Spa typing of
the PVL positive isolates. Only two of the 36 isolates
could not be typed by this technique, but they belonged
to the same pulsotype (A1). In all, there were 13 Spa
types among the 34 typable PVL positive S. aureus iso-
lates. The most prevalent Spa types were t318 compris-
ing of 26.5% (n = 9), of which seven isolates carried the
mecA gene; and t645 (20.6%, n = 7). The other common
Spa types were and t11656 (8.8%, n = 3) and t127 (n = 3).
The other Spa types, their frequencies and PFGE profiles
can be seen in Table 1.
Discussion
Knowledge of the epidemiology of bacterial infections is
very important for appropriate decision-making in the
treatment of arising infections. At a community level, it
is also important to curb the spread of infection, in-
cluding multidrug resistant strains. To our knowledge,
this is the first investigation of Panton-Valentine
Leukocidin-Positive CA-MRSA in asymptomatic semi-
nomadic pastoralist communities in the East African
region. The main findings of the study are a high preva-
lence of MRSA and PVL-positive isolates with a pre-
dominant spa type (t318).
This study isolated 132 Staphylococci isolates from the
nares of 253 participants, of which 73 were coagulase
positive S. aureus (carriage rate of 29%). The 73 isolates
of S. aureus in our study were obtained from 48 male
and 25 female participants, with an average age of
13 years, with 56/73 (76. 7%) of the participants being
between 7 and 15 years old. This is similar to observa-
tions elsewhere that CA-MRSA infections tend to occur
in previously healthy younger patients [21, 32, 33]. Our
finding is of public health importance because this
school-going age group has potential of disseminating
the strains far and wide in the communities. The car-
riage rate in our study is more than double that in a
study on milk men in and around Kampala city, Uganda,
where only 11 Staphylococci were isolated from 31 indi-
viduals, of which only 4/31 (13%) were S. aureus [26].
Our finding, however, is in agreement with statistics
from literature suggesting that between 25 to 35% of
Table 2 PFGE profiles, mecA, and SCCmec types of PVL
negative isolates
Isolate ID Pulsotype Spa type mecA SCCmec
T117Nb E1 t786 - -
T119Na E1 t786 - -
T092Na E2 t186 - -
T058Nb E4 t7662 - -
T061Nd L1 t1236 + V
T061Nb L1 t1236 + V
T059Na L2 Unknown + V
T059Nb L3 Unknown + V
T099Na L3 Unknown + V
T021Nd L4 Unknown + V
T032Nc F1 t064 - -
T131Nb F1 t064 - -
T032Nb F1 T064 - -
T061Nc N1 t2771 + V
T074Nc N1 t2771 + V
T074Nb N1 t2771 + V
T029Nb H1 t002 - -
T101Nf H1 t002 + V
T076N G1 t5739 + V
T128Nd G1 t2680 + V
T018Nb G2 t616 + V
T092Nb P1 t4353 + V
T102Nb P2 t4353 - -
T127Na Q1 Unknown - -
T137Ng Q1 t064 - -
T110Nb R1 t4523 - -
T111Na R2 t5187 + V
T027Nb R3 t5187 + V
T004Nb Unique t3772 + V
T033Nb Unique Unknown + V
T005Nb Unique t951 + V
T114Ng Unique Unknown - -
T151Nb Unique t5739 + V
T115Na Unique Unknown + IVa
T120N Unique t5187 + V
T126N Unique NT + IVa
T104Nb Unique Unknown - -
ID identification number of the isolate
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healthy individuals are asymptomatically colonized with
S. aureus in the nostrils [1, 21, 34, 35].
In the current study, the proportion of S. aureus iso-
lates carrying the mecA gene, hence MRSA, was 48/73
(65.8%). This is generally high in comparison to commu-
nity studies elsewhere. In the urban and peri-urban
Kampala, the four isolates from milk men were all
MSSA. In a study of indigenous remote African Babongo
pygmies living in Waka National Parc, Central Gabon,
all 34 S. aureus isolates were susceptible to Oxacillin/
Methicillin, and did not amplify for the mecA gene by
PCR. The authors hypothesized that the result could be
due to limited use of antibiotics in that population. Stud-
ies in North America and Australia, however, have
shown that native and indigenous populations have been
associated with a high risk of colonization and infection
with CA-MRSA which may be related to many of these
groups being disadvantaged, due to their association
with low socio-economic status, crowded living condi-
tions and frequent use of antibiotics [36, 37]. There have
been reports of absolute resistance to penicillin and high
percentage resistance to other antibiotics in milk from
similar settings in central Uganda, hence risk of spread
to humans through the food chain [27]. In our study
community there is frequent usage, by farmers, of veteri-
nary antibiotics to treat nearly all ailments in their live-
stock, due to poor outreach services by the veterinary
department. It is therefore more likely that constant
contact with antibiotics for animal use, as well as
consumption of raw milk and its products without ob-
serving drug withdrawal periods, as is the culture in this
setting, are limiting future options for the management
of multidrug resistant microorganisms in both humans
and animals in pastoral communities of Uganda. Among
the 48 isolates carrying the mecA gene, 39 (81.3%) were
type V, the other being type IV or its subtypes (Tables 1
and 2). Type IV and V SCCmec elements have strongly
been associated with stains causing MRSA infections in
persons with no history of hospitalization, hence thought
to be more related to CA-MRSA [38]. Furthermore, it
has been shown that children may be at a higher risk of
infection with SCCmec types IV and V, as well as PVL
carrying strains, compared to adults [38, 39]. SCCmec
type V, which comprised of 81.3% of the mecA positive
strains in our study, is known to be rare in Europe and
the United States [33], and only recently seen in Greece
[40]. Because SCCmec type IV and V are known to be
small and highly mobile elements, their dissemination in
a community population may be most commonly by
transfers of strains from carriers to other individuals or
from MRSA strains to Methicillin Sensitive Staphylococcus
aureus (MSSA strains), or even from coagulase-negative
staphylococci strain to an MSSA strain [41]. However, a
recent study on patients with surgical site infections (SSI)
at the National Referral hospital in Mulago, Kampala,
showed that SCCmec type V was the most predominant
type [22], suggesting the presence of mixed CA-MRSA
and HA-MRSA genotypes in hospital settings in Uganda.
A further characterization of the 36 isolates carrying
the PVL gene in this study was done. SCCmecIV and
PVL are known to be molecular markers associated with
the emergence of CA-MRSA worldwide [10]. The pro-
portion of strains carrying both the PVL and mecA
genes was 25/36 (69.4%), while the mecA gene was de-
tected in 23/37 (62.2%) of the isolates without the PVL
gene. While there was no significant difference in mecA
carriage, PFGE profiles for both PVL positive and nega-
tive isolates show that there were bigger clusters in PVL
positive strains (Table 1) compared to PVL negative
strains (Table 2). In fact, 18/37 (48.6%) of the PVL
negative isolates were in clusters (Table 1) compared to
21/36 (58.3%) of PVL positive isolates, with the largest
(B1) comprising of eight isolates (Table 1). These re-
sults suggest that PVL positive isolates in the study
were more likely to be involved in chains of transmis-
sion compared to the PVL negative isolates. There has
been recent evidence of familial spread of PVL carrying
MSSA strains in Israel [42] and MRSA strains in Italy
[43], while a previous study in Greece revealed that a
unique clone of PVL-positive MRSA had spread in both
the community and hospital settings, and was replacing
older clonal types [44]. In Central Gabon, Africa, PVL-
encoding genes were detected in 55.9% of study iso-
lates, with authors concluding that the pygmies in that
study faced a risk of developing necrotizing infections,
due to the virulence characteristic of the PVL. The
finding of a high proportion of isolates carrying both
the PVL and mecA genes in our study may have
considerable implications on future strategies for infec-
tion control in these underprivileged communities.
Among the PVL positive isolates, there was a predomi-
nant circulating Spa type, t318, comprising of nine of the
34 (26.5%) typable isolates. This is the first time the Spa
type has been identified in a Ugandan setting. Moreover,
seven strains (77.8%) of this Spa type carried the mecA
gene, pointing to the presence of a potentially virulent
methicillin resistant strain circulating in the community.
This strain has been found to be pandemic, and mostly
PVL positive, also denoted ST30 by multilocus sequence
typing. It has recently been mapped to have originated
from Australia and disseminated to Brazil, United States,
South Africa and Western Europe [3]. However, it is not
related to the USA300, belonging to ST8 and leading cause
of CA-MRSA in the USA. It has been revealed that PVL is
most frequent in pandemic CA-MRSA strains and certain
MSSA lineages, including ST30, appear to be a reservoir of
CA-MRSA [6]. Surprisingly, ST30 has also been isolated
from Babongo pygmies of Gabon in Africa, who are known
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to have been separated from other humans over millennia
ago [21]. In a study of MRSA in five African cities, only
one strain of this type was isolated from Antananarivo,
and none from Cassablanca (Moroco), Niamey (Niger),
Dakar (Senegal) and Yaoundé (Cameroon). While SCCmec
type V strains have been isolated from hospital settings in
Uganda, none were Spa type t318 [22]. However, Spa type
t645, the second most frequent type in our collection
(20.6%), also common in Western Europe and the Middle
East (http://spaserver.ridom.de), was found to be the most
frequent type isolated from SSI at Mulago National refer-
ral hospital [22], supporting the notion that there is a
changing epidemiology reflected by community associated
SCCmec genotypes being now more associated with hos-
pital infections as observed elsewhere [23, 45]. However, it
is noteworthy that some spa types of PVL+ S. aureus in
the present study (t186, t729 and t355) have been pre-
viously identified in studies from Africa, and they all
share the MLST type ST88 [46].
Conclusion
The main findings of this study are a high prevalence of
CA-MRSA, and PVL-positive isolates with a predominant
spa type in a rural setting in Uganda. This has implication
on future strategies for infection control in these under-
privileged communities because of possibility of limited
treatment options. Antimicrobial stewardship programs
may be necessary in Uganda so as to create awareness and
avert possible emergence multidrug resistant microor-
ganisms in the near future.
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